Improved outcomes with surgery

Authors

• Olugbenga T Okusanya
• Nick Hess
• Neil Christie
• James D Luketich
• Inderpal S Sarkaria

Publication/Presentation Date

12-1-2016

Abstract

Myasthenia gravis can be a debilitating neurological disorder that affects thousands worldwide. Thymectomy has historically been considered in patients refractory to medical therapy or with concurrent thymoma. While retrospective data and propensity matched trials have favored thymectomy in order to decrease disease severity and disease associated morbidity, no randomized data existed to clearly delineate the benefit of this practice. The reviewed paper by Wolfe

Volume

4

Issue

24

First Page

526

Last Page

526

ISSN

2305-5839

Published In/Presented At

Okusanya, O. T., Hess, N., Christie, N., Luketich, J. D., & Sarkaria, I. S. (2016). Improved outcomes with surgery vs. medical therapy in non-thymomatous myesthenia gravis: a perspective on the results of a randomized trial. Annals of translational medicine, 4(24), 526. https://doi.org/10.21037/atm.2016.12.54

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

28149887

Department(s)

Administration and Leadership

Document Type

Article